The tests to do are shown in
the table below:
Gender /
Sexuality
|
Blood test
(HIV &
Syphilis)
|
Urine test
(Chlamydia & Gonorrhoea)
|
Throat swab
(Chlamydia & Gonorrhoea)
|
Anal swab
(Chlamydia & Gonorrhoea)
|
Vaginal swab
(Chlamydia & Gonorrhoea)
|
Male heterosexual
|
Yes
|
Yes
|
|
|
|
Woman
|
Yes
|
|
?
|
?
|
Yes
|
Man who has sex
with men
|
Yes
|
Yes
|
Yes
|
Yes
|
|
? Testing the
throat & rectum in women depends on the sexual history
These sensitive tests can
accurately rule out an infection if they are done after what is known as the
'window period', which is two weeks for Chlamydia / Gonorrhoea and six weeks for
Syphilis / HIV. If low risk individuals
are tested then the numbers of individuals to test to find one infection is
high. For example if 1% of the tested
population has a single infection then 100 people would need to be tested to
find one infection. The National Chlamydia Screening
Program tests young people less than 25 years of age because the prevalence
of infection in this group is around 10%; consequently, for every ten young
people tested one Chlamydia infection is found.
The picture below shows the
analysis from Guy's & St Thomas' from the first six months of 2015 for
Gonorrhoea. This bacterium is important
because it is very infectious and it evolves
antibiotic resistance over time. In
the UK, Gonorrhoea is mostly diagnosed in men who have sex with men and in
heterosexual from the Black African / Caribbean community.
This data shows the importance
of informing partners and getting them tested.
One in three partners need to be tested to find one Gonorrhoea
infection. There is no difference in the
number of male & female partners that need to be tested to find one infection in this analysis even
though there are 17 times more diagnoses of Gonorrhoea in men (1 in 16 versus 1 in 283).
IF all contactable partners of an STI are
informed & tested then it would be theoretically possible to significantly reduce an infection
from a sexual network; however, to date no single tool has been developed to
support the person with the infection, partners and providers to effectively
deliver partner notification and measure the impact of this important
service.